August 19, 2013. Selexys Pharmaceuticals Initiates SUSTAIN Phase 2 Clinical Trial in Sickle Cell Patients with Pain Crises. September 19, 2012. Selexys Pharmaceuticals Completes $23M Equity Financing and Signs Agreement With Global Pharmaceutical Company. February 29, 2012. Work on sickle cell drug advances. Welcome to Selexys Pharmaceuticals.
http://www.selexys.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Sunday
LOAD TIME
0.3 seconds
Selexys Pharmaceuticals
840 Res●●●●●●●Parkway
Sui●●●510
Okla●●●●City , Oklahoma, 73104
United States
View this contact
Selexys Pharmaceuticals
840 Res●●●●●●●Parkway
Sui●●●510
Okla●●●●City , Oklahoma, 73104
United States
View this contact
Selexys Pharmaceuticals
840 Res●●●●●●●Parkway
Sui●●●510
Okla●●●●City , Oklahoma, 73104
United States
View this contact
BUY YOUR DOMAIN
20
YEARS
5
MONTHS
19
DAYS
GODADDY.COM, LLC
WHOIS : whois.godaddy.com
REFERRED : http://registrar.godaddy.com
PAGES IN
THIS WEBSITE
7
SSL
EXTERNAL LINKS
1
SITE IP
50.63.37.1
LOAD TIME
0.313 sec
SCORE
6.2
Selexys Phamaceuticals | selexys.com Reviews
https://selexys.com
August 19, 2013. Selexys Pharmaceuticals Initiates SUSTAIN Phase 2 Clinical Trial in Sickle Cell Patients with Pain Crises. September 19, 2012. Selexys Pharmaceuticals Completes $23M Equity Financing and Signs Agreement With Global Pharmaceutical Company. February 29, 2012. Work on sickle cell drug advances. Welcome to Selexys Pharmaceuticals.
selexys.com
Selexys Phamaceuticals Team
http://www.selexys.com/about.html
Scott Rollins, Ph.D. - President and CEO. Russell Rother, Ph.D. - Executive Vice President and COO. David Falconer, MS, MBA - Vice President of Business and Drug Development. Richard Alvarez, M.B.A. - Vice President of Operations and Research. Jonathan Stocker, Ph.D. - Senior Director of Clinical Development. Ziad Kawar, Ph.D. - Senior Scientist. Rodger P. McEver, M.D. - Co-founder and Board Member. Richard D. Cummings, Ph.D. - Co-founder.
Selexys Phamaceuticals News
http://www.selexys.com/news/2013-08-19.html
Selexys Pharmaceuticals Initiates SUSTAIN Phase 2 Clinical Trial in Sickle Cell Patients with Pain Crises. SUSTAIN study to investigate the potential of a chronic SelG1 therapy to reduce or prevent the occurrence of sickle cell-related pain crises. About Sickle Cell Disease.
Selexys Phamaceuticals News
http://www.selexys.com/news/2012-09-19.html
Selexys Pharmaceuticals Completes $23M Equity Financing and Signs Agreement With Global Pharmaceutical Company. Sept 19, 2012. The Series A financing includes a new major investor, MPM Capital. Concurrent with the investment, Selexys also announced the addition of Todd Foley, Managing Director of MPM Capital, to the Selexys Pharmaceuticals Board of Directors. SelG1 is a first-in-class therapeutic approach for the treatment of vasoocclusive crisis in sickle cell disease," stated Dr. Russell Rother, Se...
Selexys Phamaceuticals News
http://www.selexys.com/news/2012-02-29.html
Work on sickle cell drug advances. Feb 29, 2012. OKLAHOMA CITY – An Oklahoma City-based biopharmaceutical company is one step closer to advancing a new drug designed to treat severe sickle cell disease, and that step is also making the company more lucrative to possible partnerships with other pharmaceutical companies or venture capital groups. Moving out of Phase I also puts Selexys in a better position for seeking investors and partners to shoulder the cost of the expensive clinical trials to come.
Selexys Phamaceuticals
http://www.selexys.com/index.html
August 19, 2013. Selexys Pharmaceuticals Initiates SUSTAIN Phase 2 Clinical Trial in Sickle Cell Patients with Pain Crises. September 19, 2012. Selexys Pharmaceuticals Completes $23M Equity Financing and Signs Agreement With Global Pharmaceutical Company. February 29, 2012. Work on sickle cell drug advances. Welcome to Selexys Pharmaceuticals.
TOTAL PAGES IN THIS WEBSITE
7
Vacature zoeken
Terug naar de Selexxyz site. Salesmanager (0,6fte) (VERVULD). Vanwege groei van de organisatie zijn wij voor ENCARE ARBOZORG op .meer info. Customer Service Employee (VERVULD). Als Customer Service Employee ben je de spil tussen accountmanagement, de klanten en de diverse afdelingen binnen VMT. Daarnaast ben je verantwoordelijk voor het leggen, onderhouden en verder uitdiepen van (commerciële) contacten bij nieuwe en bestaande relaties en .meer info. Administratief medewerk(st)er fulltime (VERVULD).
ガーデン＆エクステリアのセレクシィ｜和歌山,大阪,阪南市,エクステリア,外構,リフォーム,庭,Selexy
ガーデン エクステリアのセレクシィ 和歌山,大阪,阪南市,エクステリア,外構,リフォーム,庭,Selexy,. ガーデン エクステリアのセレクシィ 和歌山,大阪,阪南市,エクステリア,外構,リフォーム,庭,S. セレクシィは大阪府阪南市にあり、和歌山 大阪のガーデン エクステリア 外構工事など、お家の外回り全般の設計 施工の専門店です。 敷地形状 地域環境 機能性 安全性を考慮し、.
selexya's blog - Blog de selexya - Skyrock.com
25/01/2010 at 2:51 PM. 27/01/2010 at 1:26 AM. Subscribe to my blog! Lylloo dou di dam. Add this video to my blog. Voila un deuxieme clip de lylloo! Don't forget that insults, racism, etc. are forbidden by Skyrock's 'General Terms of Use' and that you can be identified by your IP address (66.160.134.4) if someone makes a complaint. Please enter the sequence of characters in the field below. Posted on Wednesday, 27 January 2010 at 1:26 AM. LYLLOO - MON TEL. Add this video to my blog. Edited on Tuesday, 26 ...
selexyacht.com - This website is for sale! - selexyacht Resources and Information.
The owner of selexyacht.com. Is offering it for sale for an asking price of 299 USD! This page provided to the domain owner free. By Sedo's Domain Parking. Disclaimer: Domain owner and Sedo maintain no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo or domain owner and does not constitute or imply its association, endorsement or recommendation.
Selexys Phamaceuticals
August 19, 2013. Selexys Pharmaceuticals Initiates SUSTAIN Phase 2 Clinical Trial in Sickle Cell Patients with Pain Crises. September 19, 2012. Selexys Pharmaceuticals Completes $23M Equity Financing and Signs Agreement With Global Pharmaceutical Company. February 29, 2012. Work on sickle cell drug advances. Welcome to Selexys Pharmaceuticals.
TransIP - Reserved domain
This is the standard TransIP page for reserved domain names. No website has been published for this domain. Are you still seeing. This after publishing your website? Please make sure you upload your website to the /www directory and clear your browser cache before reloading this page. Domains and Web hosting. Dit domein is gereserveerd. U kijkt naar de standaardpagina van TransIP. Voor deze domeinnaam is nog geen website gepubliceerd. Heeft u de bestanden van. Dit domein is gereserveerd.
TransIP - Reserved domain
This is the standard TransIP page for reserved domain names. No website has been published for this domain. Are you still seeing. This after publishing your website? Please make sure you upload your website to the /www directory and clear your browser cache before reloading this page. Domains and Web hosting. Dit domein is gereserveerd. U kijkt naar de standaardpagina van TransIP. Voor deze domeinnaam is nog geen website gepubliceerd. Heeft u de bestanden van. Dit domein is gereserveerd.
TransIP - Reserved domain
This is the standard TransIP page for reserved domain names. No website has been published for this domain. Are you still seeing. This after publishing your website? Please make sure you upload your website to the /www directory and clear your browser cache before reloading this page. Domains and Web hosting. Dit domein is gereserveerd. U kijkt naar de standaardpagina van TransIP. Voor deze domeinnaam is nog geen website gepubliceerd. Heeft u de bestanden van. Dit domein is gereserveerd.
selexyz persberichten
Eerste schrijver verkoopt alle aandelen op TenPages.com. Selexyz stimuleert schrijftalent met TenPages.com. Conny Smulders, selexyz. E conny.smulders@selexyz.nl. Selexyz is de grootste boekenverkoper van Nederland en is voor het vijfde achtereenvolgende jaar door het publiek verkozen tot Beste Boekwinkel van Nederland. Tot de selexyz boekhandels behoren: selexyz adr. heinen, selexyz broese, selexyz dekker v.d. vegt, selexyz de tille, selexyz dominicanen, selexyz donner, selexyz gianotten,...
